← Leaderboards
Charles Corbin Bailey
Emmune, Inc
$625,153
Attributed
$1,218,204
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $886.1K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$1,218,204 · 2
By mechanism
R44$1,218,204 · 2
Top collaborators
- Michael David Alpert2 shared
Others in their field
Other Emerging Leaders on “Transgenes”
- Benjamin E Deverman · Broad Institute, Inc.$11,628,265
- Niccolo Terrando · Duke University$8,830,731
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$7,070,880
- Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru$6,670,587
- William Raymond Lagor · Baylor College Of Medicine$6,500,004
- Erin R Hascup · Southern Illinois University Sch Of Med$6,437,215
Research focus
TransgenesInhibitor/AntagonistProteinsImmunogenicCell Culture TechniquesDependovirusNeutralizing AntibodyPharmaceutical PreparationsSafetyVariantSerumDoseAnimalsPeptidomimeticsAntibodiesHiv-1Hiv-2GenerationsCostFitnessHalf-LifeEpitopesAntiretroviral TherapyExhibits
Grant awards (3)
Engineering AAV capsids for enhanced transduction of skeletal muscle$32,101
R44 · FY2021 · TR · contact PI
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig$886,103
R44 · FY2020 · AI · contact PI
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig$300,000
R44 · FY2019 · AI · contact PI